Shortage Avoided

XARELTO

BAYER INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of XARELTO in Canada?

Not currently. The most recent shortage report for XARELTO 51.7MG is marked resolved (last updated February 9, 2022).

Can I still get this?Check with your pharmacist

StatusShortage Avoided

Same-ingredient products on fileNone found

Affected strength51.7MG

Last updated2022-02-09

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02510162

Strength

51.7MG

Dosage Form

GRANULES FOR SUSPENSION

Route

ORAL

Active Ingredient

RIVAROXABAN

Tier

Unrated

Last Updated

2022-02-09

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

XARELTO has 2 shortage/discontinuation reports on file — this is one of them.

2023-11-17

Shortage Avoided

Shortage of an inactive ingredient or component.

Other Products from BAYER INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

60MG · DIN 02155990

20MG · DIN 02237618

30MG · DIN 02155907

0.5MG · DIN 02412764

2MG · DIN 02412802

2.5MG · DIN 02412810